Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Kezar Life Sciences (KZR) Other Gross PP&E Adjustments (2021 - 2025)

Kezar Life Sciences (KZR) has disclosed Other Gross PP&E Adjustments for 5 consecutive years, with $2.7 million as the latest value for Q4 2025.

  • For Q4 2025, Other Gross PP&E Adjustments fell 63.75% year-over-year to $2.7 million; the TTM value through Dec 2025 reached $2.7 million, down 63.75%, while the annual FY2025 figure was $2.7 million, 63.75% down from the prior year.
  • Other Gross PP&E Adjustments hit $2.7 million in Q4 2025 for Kezar Life Sciences, down from $8.1 million in the prior quarter.
  • Across five years, Other Gross PP&E Adjustments topped out at $8.1 million in Q3 2025 and bottomed at -$2.7 million in Q4 2022.
  • Average Other Gross PP&E Adjustments over 5 years is $3.3 million, with a median of $3.1 million recorded in 2021.
  • Year-over-year, Other Gross PP&E Adjustments crashed 187.76% in 2022 and then soared 625.65% in 2025.
  • Kezar Life Sciences' Other Gross PP&E Adjustments stood at $3.1 million in 2021, then tumbled by 187.76% to -$2.7 million in 2022, then skyrocketed by 262.19% to $4.4 million in 2023, then skyrocketed by 65.19% to $7.3 million in 2024, then crashed by 63.75% to $2.7 million in 2025.
  • According to Business Quant data, Other Gross PP&E Adjustments over the past three periods came in at $2.7 million, $8.1 million, and $7.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.